Celltrion Inc. FDA Record
- Latest inspection VAI · May 3, 2024
- Last warning letter 2018
Celltrion Inc. has 0 FDA recalls, 7 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Celltrion Inc., the most recent on Jan 29, 2018. FDA has published 1 Form 483 for Celltrion Inc..
- Latest inspection
- May 3, 2024 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 7 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Celltrion Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 2 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 1 | 0 | 0 |
| 2017 | 1 | 1 | 0 | 0 | 0 |
Reviewing Celltrion Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Celltrion Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Celltrion Inc. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Jan 29, 2018 · Record page |
Celltrion Inc. Form 483s
| Date | Document | FEI |
|---|---|---|
| Jul 17, 2018 · Document on fda.gov | 483 | 3005241015 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| May 3, 2024 | Yeonsu, Korea (The Republic Of) | Drugs | Voluntary Action Indicated (VAI) | 3005241015 |
| Feb 27, 2024 | Yeonsu, Korea (The Republic Of) | Drugs | Voluntary Action Indicated (VAI) | 3005241015 |
| Jun 3, 2022 | Yeonsu, Korea (The Republic Of) | Drugs | Voluntary Action Indicated (VAI) | 3005241015 |
| Oct 22, 2019 | Yeonsu, Korea (The Republic Of) | Drugs | Voluntary Action Indicated (VAI) | 3005241015 |
| Jul 17, 2018 | Yeonsu, Korea (The Republic Of) | Drugs | Voluntary Action Indicated (VAI) | 3005241015 |
| Jun 2, 2017 | Yeonsu, Korea (The Republic Of) | Drugs | Official Action Indicated (OAI) | 3005241015 |
| Apr 9, 2015 | Yeonsu, Korea (The Republic Of) | Drugs | No Action Indicated (NAI) | 3005241015 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Celltrion Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3005241015 | Yeonsu, Korea (The Republic Of) | 7 | May 3, 2024 |
Celltrion Inc. and the FDA: common questions
Has Celltrion Inc. received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Celltrion Inc.. The most recent is dated Jan 29, 2018.
Has Celltrion Inc. received an FDA Form 483?
FDA has published 1 Form 483 for Celltrion Inc. in its reading room, the most recent dated Jul 17, 2018. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Celltrion Inc.?
The most recent FDA inspection on file ended May 3, 2024 at Yeonsu, Korea (The Republic Of) and was classified VAI. FDA has 7 inspections of Celltrion Inc. on file, 1 of them classified OAI (official action indicated).
Need more than this page shows? Ask about Celltrion Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.